Nephros Inc
NASDAQ:NEPH

Watchlist Manager
Nephros Inc Logo
Nephros Inc
NASDAQ:NEPH
Watchlist
Price: 3.89 USD 1.83% Market Closed
Market Cap: $41.4m

Nephros Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nephros Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Nephros Inc
NASDAQ:NEPH
Other Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Whirlpool Corp
NYSE:WHR
Other Items
-$115m
CAGR 3-Years
66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hamilton Beach Brands Holding Co
NYSE:HBB
Other Items
$4.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cricut Inc
NASDAQ:CRCT
Other Items
$85.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vesync Co Ltd
HKEX:2148
Other Items
-$72.8m
CAGR 3-Years
-20%
CAGR 5-Years
-161%
CAGR 10-Years
N/A
S
Sharkninja Inc
NYSE:SN
Other Items
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Nephros Inc
Glance View

Market Cap
41.4m USD
Industry
Consumer products

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 34 full-time employees. The company went IPO on 2004-09-21. The firm segments include Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment primarily develops and sells high performance water purification filters. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. The Company’s pathogen detection systems are portable, near real-time systems designed to provide actionable data for infection control teams and other organizations. Its subsidiaries include Nephros International Limited and Specialty Renal Products, Inc.

NEPH Intrinsic Value
2.76 USD
Overvaluation 29%
Intrinsic Value
Price

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett